Blood test may predict deadly clots in cancer patients
NCT ID NCT06051214
First seen Feb 22, 2026 · Last updated May 16, 2026 · Updated 9 times
Summary
This study is looking at whether a blood test that measures a clotting factor called thrombin can predict which cancer patients are at risk for dangerous blood clots. The researchers will follow 200 adults with high-risk solid tumors (lung, pancreatic, stomach, or brain cancer) for 12 months after they start treatment. The goal is to develop a simple test that doctors can use to identify patients who need clot prevention.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Cancerologie de L'Ouest
RECRUITINGSaint-Herblain, 44805, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.